DELVINO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 2.913
NA - Nord America 1.115
EU - Europa 1.021
SA - Sud America 581
AF - Africa 46
OC - Oceania 13
Totale 5.689
Nazione #
US - Stati Uniti d'America 1.042
SG - Singapore 809
CN - Cina 623
VN - Vietnam 557
BR - Brasile 465
HK - Hong Kong 425
RU - Federazione Russa 338
IT - Italia 310
JP - Giappone 146
KR - Corea 106
DE - Germania 60
AR - Argentina 52
GB - Regno Unito 50
FR - Francia 49
ID - Indonesia 45
IN - India 41
ES - Italia 40
SE - Svezia 36
MX - Messico 32
TR - Turchia 31
CA - Canada 30
BD - Bangladesh 26
NL - Olanda 22
ZA - Sudafrica 19
IE - Irlanda 17
IQ - Iraq 16
CO - Colombia 14
VE - Venezuela 14
AT - Austria 13
AU - Australia 13
EC - Ecuador 13
PK - Pakistan 13
CH - Svizzera 12
FI - Finlandia 12
UA - Ucraina 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
PL - Polonia 10
TW - Taiwan 10
BE - Belgio 8
EG - Egitto 7
CL - Cile 6
MA - Marocco 6
TH - Thailandia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
HR - Croazia 5
PE - Perù 5
DZ - Algeria 4
IL - Israele 4
LB - Libano 4
LT - Lituania 4
PY - Paraguay 4
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
RO - Romania 3
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DM - Dominica 1
HN - Honduras 1
IM - Isola di Man 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.689
Città #
Singapore 474
Hong Kong 422
Hefei 243
Ashburn 237
Ho Chi Minh City 177
Hanoi 167
Seoul 102
Beijing 83
Milan 83
Dallas 57
Ann Arbor 54
Los Angeles 53
Tokyo 51
Moscow 43
The Dalles 39
Buffalo 38
São Paulo 34
Santa Clara 33
Jakarta 32
Shanghai 32
Turin 31
New York 23
Rio de Janeiro 19
Biên Hòa 18
Da Nang 18
Dublin 17
Quận Bình Thạnh 16
Madrid 15
Osaka 15
Rome 15
Florence 14
Belo Horizonte 13
Chicago 12
Frankfurt am Main 12
Hải Dương 12
Mexico City 12
Amsterdam 11
Buenos Aires 11
Kent 11
Paris 11
Ryōke 11
Tashkent 11
Carate Brianza 10
Guangzhou 10
Montreal 10
Nuremberg 10
Stockholm 10
Chennai 9
Munich 9
Salt Lake City 9
Seattle 9
Ankara 8
Haiphong 8
Houston 8
Istanbul 8
Salvador 8
Vienna 8
Brasília 7
Brescia 7
Denver 7
Ha Long 7
Johannesburg 7
Lappeenranta 7
Mumbai 7
Ninh Bình 7
Recife 7
Ribeirão Preto 7
Taiyuan 7
Toronto 7
Bern 6
Bogotá 6
Brooklyn 6
Caracas 6
Chandler 6
Curitiba 6
Fairfield 6
Guayaquil 6
London 6
Manaus 6
Matsuyama 6
Porto Alegre 6
Quito 6
Quận Một 6
Riyadh 6
Vũng Tàu 6
Wilmington 6
Ahmedabad 5
Barcelona 5
Belém 5
Blumenau 5
Bologna 5
Boston 5
Brussels 5
Camden 5
Can Tho 5
Caxias do Sul 5
Charlotte 5
Hangzhou 5
Lima 5
Madone 5
Totale 3.172
Nome #
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 484
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study 276
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 246
Systemic vasculitis: one year in review 2024 216
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 179
Systemic vasculitis: one year in review 2022 170
Approccio innovativo agli unmet needs nella gestione a lungo termine dei pazienti affetti da vasculite ANCA-associata 169
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 167
Novel insights into the management of rheumatoid arthritis: one year in review 2024 155
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 148
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 133
Clinical picture, outcomes and predictors of relapse in eosinophilia-associated coronary vasospasm: data from a European multicentric study 121
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 121
Systemic vasculitis: one year in review 2025 112
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polangiitis in a patient treated with dupilumab 111
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 104
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: A prospective analysis 101
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 100
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 99
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 96
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire 95
Asma, EGPA, HES: elementi di diagnostica differenziale 92
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 91
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 91
A 28-Year-Old Man with Stridor and Dyspnea 88
Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis 87
Set the scene: Key points dell’Inquadramento e diagnosi differenziale dell’EGPA 84
Update on Treatment of Antisynthetase Syndrome: A Brief Review 83
Systemic vasculitis: one year in review 2023 81
Novel Therapies for ANCA-associated Vasculitis 79
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 78
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis 78
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 76
Quale approccio diagnostico al paziente con iper-eosinofilia? 76
A New Era for the Early and Non‐Invasive Diagnosis of Giant Cell Arteritis: The Use of Fast‐Track Ultrasound in Clinical Practice 75
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 75
Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study 73
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 73
One year in review 2020: vasculitis 72
Asma ed ipereosinofilia 72
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 70
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 68
One year in review 2021: Systemic vasculitis 67
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 65
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 65
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis 64
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 63
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 63
Prevalence of Whipple's disease in north-western Italy 63
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 61
ANCA-Associated Vasculitides and Polyarteritis Nodosa - EULAR on-line course on Rheumatic Diseases 59
An unusual reno-pulmonary complication in the course of systemic sclerosis 58
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 58
Striking abdominal aortic stenosis revealing Takayasu's arteritis 56
Erratum: Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis (Rheumatology (2020) 59 (e125-e127) DOI: 10.1093/rheumatology/keaa184) 53
Asma e poliposi nasale: quando preoccuparsi? 49
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study 6
Totale 5.915
Categoria #
all - tutte 19.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 9 13 10
2021/202273 12 9 7 10 12 8 6 1 1 3 1 3
2022/202337 4 12 4 2 1 5 1 2 6 0 0 0
2023/2024334 0 1 1 0 7 9 9 0 131 11 50 115
2024/20252.822 154 265 68 112 167 97 194 83 219 334 298 831
2025/20262.617 610 481 432 559 339 196 0 0 0 0 0 0
Totale 5.915